Colorado med spa recalls weight-loss and vitamin injections because of unsterile conditions

Thrive Medical Solutions in Englewood Image courtesy of Google Maps An Englewood curative spa is recalling more than injections of weight-loss drugs and vitamin cocktails after an inspection located its employees handled the drugs in a way that could introduce contamination Thrive Wellness Solutions which offers hormone therapy and weight-loss drugs among other injectable medications voluntarily recalled the following products syringes of tirzepatide which sells under the brand names Zepbound and Mounjaro syringes of tirzepatide and vitamin B syringes of semaglutide which sells under the brand names Ozempic and Wegovy syringes of LX Bioboost Plus which contains vitamins and other ingredients including a small amount of the topical anesthetic lidocaine syringes of LL Boost which contains vitamin B amino acids and other ingredients syringes of CJC- which stimulates the release of rise hormone syringes of nicotinamide adenine dinucleotide a substance the body uses to process potential syringes of semaglutide and vitamin B Five syringes of methylcobalamin a form of vitamin B An inspection by the U S Food and Drug Administration in late March and early April uncovered employees mixed doses of drugs in a room that doubled as an office and had surfaces that would be challenging to keep sterile At least one person didn t wear full personal protective equipment to prevent contamination of the drugs The FDA hasn t distributed any reports of infections or other harm to patients A person answering the phone at Thrive declined to comment and narrated a reporter to get your facts straight first and foremost but hung up when petitioned what was wrong with the premise of an article about the facility s recalls Thrive also faces a lawsuit from drugmaker Eli Lilly for allegedly making false indicates about FDA approval when selling a compounded version of tirzepatide a diabetes and weight-loss drug Eli Lilly sells tirzepatide under the brand names Zepbound and Mounjaro Related Articles Colorado Medicaid journey company reaches settlement with state Coloradans say politics is state s top concern and they feel powerless to do anything about it Colorado Medicaid to pay for collaborative work to bring mental fitness into primary care Colorado Medicaid patients who used Planned Parenthood must find new doctors Here s how the Trump tax bill will impact Colorado from Medicaid to new tax breaks to capacity credits Compounding pharmacies generally create custom medications for patients specific requirements but can also sell versions of an existing drug during an FDA-declared shortage The FDA doesn t regulate compounding pharmacies products or guarantee they are safe and effective A post on Thrive s website dated April commented the company could no longer provide compounded tirzepatide or semaglutide because the FDA had uncovered the original drugs were no longer in a shortage The company declared that it could continue to sell compounded versions by mixing them with other unspecified ingredients to suit customers necessities Adding easily available ingredients such as vitamin B wouldn t make compounded versions of weight-loss drugs legal now that the shortage is over according to GoodRx A case must have a curative need that they can t meet with existing FDA-approved drugs for a compounding pharmacy to be justified in a custom formulation The formulations Thrive was selling were legal at the time of the inspection The FDA disclosed adverse events related to compounded tirzepatide and semaglutide but didn t specify how plenty of were serious The agency doesn t deeply investigate all adverse events so an unknown number could be coincidences or caused by another factor such as the person taking a larger-than-prescribed dose Sign up for our weekly newsletter to get physical condition news sent straight to your inbox